Tomoaki Koshizawa

Synthesis of 2,6-dimethyl-9-aryl-9-phosphabicyclo[3.3.1]nonanes: their application to asymmetric synthesis of chiral tetrahydroquinolines and relatives

O. Hara, Y. Hamada, K. Makino, 2007 .

Discovery of a 2-hydroxyacetophenone derivative as an outstanding linker to enhance potency and β-selectivity of liver X receptor agonist.

Yuichiro Watanabe, Y. Matsumoto, Tomoaki Koshizawa, 2016, Bioorganic & medicinal chemistry.

A facile method for converting alcohol to thioether and its application in the synthesis of a novel GPR119 agonist

Tomoaki Koshizawa, K. Shibuya, Y. Yamazaki, 2015 .

Synthesis of novel chiral 1,3-aminophenols and application for the enantioselective addition of diethylzinc to aldehydes

T. Hirose, Tomoaki Koshizawa, M. Yasutake, 2007 .

Optimization of a novel series of potent and orally bioavailable GPR119 agonists.

Tomoaki Koshizawa, Tomoaki Fukuda, T. Morimoto, 2017, Bioorganic & medicinal chemistry letters.

A PRACTICAL SYNTHESIS OF (4-(SPIRO[CHROMANE-2,4'-PIPERIDIN]-6-YL)PHENYL)METHANOL AS A KEY INTERMEDIATE OF NOVEL GPR119 AGONIST

Tomoaki Koshizawa, Gen Watanabe, Hayato Hosoi, 2014 .

Synthesis of Novel Chiral 1,3-Aminophenols and Application for the Enantioselective Addition of Diethylzinc to Aldehydes.

T. Hirose, Tomoaki Koshizawa, M. Yasutake, 2007 .

Discovery of novel spiro[chromane-2,4'-piperidine] derivatives as potent and orally bioavailable G-protein-coupled receptor 119 agonists.

Tomoaki Koshizawa, Tomoaki Fukuda, T. Morimoto, 2018, Bioorganic & medicinal chemistry letters.